Congenital syphilis - Annual Epidemiological Report for 2017
In 2017, 36 congenital syphilis cases were reported in 23 EU/EEA Member States, at a crude rate of 1.1 cases per 100 000 live births. The trend for reported congenital syphilis cases has remained stable in recent years.
Tularaemia - Annual Epidemiological Report for 2016
For 2016, 1 148 cases of tularaemia were reported in the EU/EEA, 1 096 (95%) of which were confirmed.
Influenza virus characterisation, Summary Europe, December 2018
This is the third report for the 2018–19 influenza season. As of week 1/2019, 18 049 influenza detections across the WHO European Region had been reported. Detections were made up of 97.7% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 2.3% type B viruses, with 16 (64%) of 25 ascribed to a lineage being B/Yamagata.
Communicable disease threats report, 13-19 January 2019, week 3
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 19-25 January 2019 and includes updates on Ebola virus disease, influenza and cholera.
Legionnaires' disease - Annual Epidemiological Report for 2017
Legionnaires’ disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate in 2017 for the EU/EEA of 1.8 per 100 000.
Hepatitis A - Annual Epidemiological Report for 2016
In 2016, 29 EU/EEA countries reported 12 502 cases of hepatitis A, of which 12 429 (99.4%) were confirmed.
ECDC country visit to Norway to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Expert consensus protocol on carbapenem resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
This expert consensus protocol for carbapenem resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the protocol for phenotypic and genotypic carbapenem resistance detection and confirmation to be used for the CCRE survey.